Caspase 3 in breast cancer

Clinical Cancer Research

Volumn 9, Issue 2, 2003, Pages 738-742

  O'Donovan, Norma ^a   Crown, John ^a   Stunell, Helen ^b   Hill, Arnold D K ^b   McDermott, Enda ^b   O'Higgins, Niall ^b   Duffy, Michael J ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA FRAGMENT; MESSENGER RNA; STEROID RECEPTOR;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER GRADING; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TUMOR VOLUME; WESTERN BLOTTING;

APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; CASPASE 3; CASPASES; ENZYME PRECURSORS; FEMALE; FIBROADENOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0037312545     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kerr, J. F., Winterford, C. M., and Harmon B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1994.
2. Evan, G. I., and Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature (Lond.), 411: 342-348, 2001.
3. Stennicke, H. R., and Salvesen, G. S. Properties of the caspases. Biochim. Biophys. Acta, 1387: 17-31, 1998.
4. Thornberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Wash. DC), 281: 1312-1316, 1998.
5. Keane, M. M., Ettenberg, S. A., Nau, M. M., Russell, E. K., and Lipkowitz, S. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res., 59: 734-741, 1999.
6. Bellarosa, D., Ciucci, A., Bullo, A., Nardelli, F., Manzini, S., Maggi, C. A., and Goso, C. Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines. J. Pharmacol. Exp. Ther., 296: 276-283, 2001.
7. Kottke, T. J., Blajeski, A. L., Martins, M., Mesner, P. W., Jr., Davidson, N. E., Earnshaws, W. C., Armstrong, D. K., and Kaufmann, S. H. Comparison of paclitaxel-, 5-fluoro-2′-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. J. Biol. Chem., 274: 15927-15936, 1999.
8. Suzuki, A., Kawabata, T., and Kato, M. Necessity of interleukin-1β converting enzyme cascade in taxotere-initiated death signaling. Eur. J. Pharmacol. 343: 87-92, 1998.
9. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, S. A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA, 92: 7162-7166, 1995.
10. Kikuchi, S., Hiraide, H., Tamakuma, S., and Yamamoto, M. Expression of wild-type p53 tumor suppressor gene and its possible involvement in the apoptosis of thyroid minors. Surg. Today, 27: 226-233, 1997.
11. Wong, S. C. C., Chan, J. K. C., Lee, K. C., and Hsiao, W. L. W. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J. Pathol., 194: 35-42, 2001.
12. Vakkala, M., Pääkö, P., and Soini, Y. Expression of caspases 3, 6, and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br. J. Cancer, 81: 592-599, 1999.
13. Bai, M., Agnantis, N. J., Kamina, S., Demou, A., Zagorianakou, P., Katsaraki, A., and Kanavaros, P. In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res., 3: 276-283, 2001.
14. Mommers, E. C. M., van Diest, P. J., Leonhart., A. M., Meijer, C. J. L. M., and Baak, J. P. A. Balance of cell proliferation and apoptosis in breast carcinogenesis. Breast Cancer Res. Treat., 58: 163-169, 1999.
15. Zhao, H., Morimoto, T., Sasa, M., Tanaka, T., and Izumi, K. Immunohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast. Breast Cancer, 9: 118-126, 2002.
16. Parton, M., Krajewski, S., Smith, I., Krajewska, M., Archer, C., Naito, M., Ahern, R., Reed, J., and Dowsett, M. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin. Cancer Res., 8: 2100-2108, 2002.
17. Kruger, S., Fahrenkrog, T., and Muller, H. Proliferative and apoptotic activity in lobular breast carcinomas. Int. J. Mol. Med., 4: 171-174, 1999.
18. Slee, E. A., Adrain, C., and Martin, S. J. Serial killer: ordering caspase activation events in apoptosis. Cell Death Differ., 6: 1067-1074, 1999.
19. Blanc, C., Deveraux, Q. L., Krajewski, S., Jänicke, R. U., Porter, A. G., Reed, J. C., Jaggi, R., and Marti, A. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res., 60: 4386-4390, 2000.
20. Yang, X-H., Sladek, T. L., Liu, X., Butler, B. R., Froelich, C. J., and Thor, A. D. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res., 61: 348-354, 2001.